Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with OMEGA CEO Raynald Aeschlimann explores the future of the brand, lessons learned, and more insights into their vision.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Antonio Bastos, founder and CEO of Omega Energia
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Azimut Exploration's Key Facts and Flagship Project Overview
00:10:00
Expanding Horizons: Financial Strength and Growth Strategy in Innovation, Biologics, and Consumer Care|Erez Israeli,Chief Executive Officer,Dr. Reddy's Laboratories Ltd
00:10:00
Khadija Ajmi, Environmental Engineer at Greenthesis Group's Remediation Office, discusses environmental initiatives, alongside an interview with Alberto Rossi, CIO.
00:10:00
Prepare to Comply with the European AI Act | Cooley AI | Patrick Van Eecke - Partner, Cooley LLP
00:10:00
David Richards, CEO of WANdisco PLC, recently discussed his company's approach to simplifying cloud technology.|David Richards, CEO of WANdisco PLC
00:00:00
Highlights Genetic Technologies (NASDAQ: GENE) -Simon Morriss, CEO, Genetic Technologies Ltd
00:10:00
Alberta Unveils Strategy and Bill 82 for Critical and Rare Earth Minerals Development
00:10:00
Quona invests in innovative fintech companies|Ganesh Rengaswamy,Managing Partner,Quona Capital
00:10:00
Top Stock Picks from Mario Gabelli: Sony, Herc, Harris, and Madison Square Garden | Mario J. Gabelli, Chief Executive Officer , Gamco Investors Inc.
00:10:00
The potential to solve some of the most pressing challenges we face|Alic Chen,General Partner,Blue Bear Ventures
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.
00:10:00
How We Started: The Journey into Financial Services